🇺🇸 FDA
Company

Ovid

Ovid Therapeutics

OVID pharma USA

Quick answer

Ovid is a pharma company (OVID) headquartered in NEW YORK, NY, USA.

Pipeline (0)

No pipeline programs linked yet.

Patents (8)

patent

US 12364708

Injectable scaffold for treatment of intracranial aneurysms and related technolo

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12358968

Utilization of CD39 and CD103 for identification of human tumor reactive T cells

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12336973

Cancer therapeutic compositions and methods targeting DNAse1L3

Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12329909

Airway management systems for pulmonary disorder treatment

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12285397

Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and

Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12185909

System and method for cleansing segments of a luminal network

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12150461

Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing t

Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12144801

Methods and compositions for treatment of epileptic disorders

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)